- 现金
- 62111 元
- 精华
- 26
- 帖子
- 30437
- 注册时间
- 2009-10-5
- 最后登录
- 2022-12-28
|
Natural course of subjects with elevated liver tests and normal liver histology
Michael Strasser1, Andreas Stadlmayr2, Heike Haufe3, Felix Stickel4, Peter Ferenci5, Wolfgang Patsch6, Alexandra Feldman1,7, Daniel Weghuber7,8, Christian Datz2,7 andElmar Aigner1,7,*
Article first published online: 6 SEP 2015
DOI: 10.1111/liv.12935
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd
Issue
Liver International
Liver International
Volume 36, Issue 1, pages 119–125, January 2016
1 First Department of Medicine, Paracelsus Medical University, Salzburg, Austria
2 Department of Internal Medicine, Oberndorf Hospital, Oberndorf, Austria
3 Department of Pathology, Paracelsus Medical University, Salzburg, Austria
4 Hepatology Unit, Clinic Beau-Site, Bern and Department of Gastroenterology and Hepatology, University Hospital Zurich, Zurich, Switzerland
5 Third Department of Medicine, Gastroenterology and Hepatology, Medical University Vienna, Vienna, Austria
6 Department of Pharmacology and Toxicology, Paracelsus Medical University, Salzburg, Austria
7 Obesity Research Unit, Paracelsus Medical Univrsity, Salzburg, Austria
8 Department of Pediatrics, Paracelsus Medical University, Salzburg, Austria
* Correspondence
Elmar Aigner, MD, First Department of Medicine, Paracelsus Medical University, Müllner Hauptstrasse 48, Salzburg A-5020, Austria
Tel: +43 662 4482 58358
Fax: +43 662 4482 51034
e-mail: [email protected]
Handling Editor: Francesco Negro
Abstract
Background & Aims
Liver biopsy (LB) is performed if non-invasive work-up of liver disease is inconclusive. The examination of liver tissue occasionally reveals normal histology. Long-term follow-up of such patients has not been performed.
Methods
We identified a total 70 subjects from our LB database with elevated liver tests and normal liver histology after a mean of 90.5 ± 52.3 (range 15–216) months and conducted reassessment of medical history, physical examination, laboratory testing, ultrasound, transient elastography and LB if indicated.
Results
At follow-up examination, 15 (7 females (f)/8 males (m); 21.4%) subjects had normal liver tests and no further evidence of liver disease. A subset of 37 (29 f/8 m; 52.9%) subjects had persistently elevated liver tests without evidence indicating progressive liver disease but the cause thereof remained unexplained also at the follow-up visit. Three (0 f/3 m; 4.3%) subjects had consumed excessive alcohol with indicators of alcoholic liver disease. Eleven subjects (4 f/7 m; 15.7%) had developed steatosis on ultrasound examination along with weight gain and/or biochemical features of the metabolic syndrome. In addition, three (2 f/1 m) patients developed autoimmune hepatitis, one female presented with primary biliary cirrhosis. One male was diagnosed with cholangiocellular carcinoma 3 months after the initial evaluation.
Conclusion
The clinical course of most patients was benign, but in approximately 20% of the subjects a liver disease developed. Particular attention should be given to autoimmune liver diseases in subjects with positive autoantibodies. In addition, lifestyle factors such as weight gain and alcohol consumption were associated with the manifestation of liver diseases.
|
|